Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/150499 
Erscheinungsjahr: 
2015
Quellenangabe: 
[Journal:] Health Economics Review [ISSN:] 2191-1991 [Volume:] 5 [Issue:] 19 [Publisher:] Springer [Place:] Heidelberg [Year:] 2015 [Pages:] 1-10
Verlag: 
Springer, Heidelberg
Zusammenfassung: 
Background: Recent studies provide evidence of improved clinical benefits associated with cardiac resynchronization therapy (CRT) optimization. Our analysis explores the cost-effectiveness of systematically optimized (SO, 3 times a year) vs. non-systematically optimized (NSO, less than 3 times a year) CRT, whatever the echo optimization method used (manual or SonR® automatic). A longitudinal cohort model was developed to predict clinical and economic outcomes for SO vs. NSO strategies over 5 years. The analysis was performed from the payer perspective. Data from CLEAR study post-hoc analysis was used with 199 pts with CRT pacemaker (CRT-P). The main economic outcome measure was incremental cost-effectiveness (ICER) expressed as cost per Quality Adjusted Life Years (QALY) gained. To assess the impact of data uncertainty, a sensitivity analysis was performed. The model also predicts outcomes for the two optimization strategies for CRT-D therapy vs. optimal medical treatment (OPT). Results: At 1 year, ICERs for SO CRT vs. NSO CRT-P range between € 22,226 (Spain) and € 26,977 (Italy). Therefore, on the basis of a Willingness-To-Pay of €30,000 per QALY, the SO method develops into a cost effective strategy from 1 year, onwards. These favorable outcomes are supported by the sensitivity analysis. Systematic optimization of CRT-D might also improve the cost-effectiveness of this device therapy by 27 % to 30 % dependent on the country analyzed, at 5 years. Conclusions: Our economic evaluation shows promising health economic benefits associated with SO CRT. These preliminary findings need further confirmation.
Schlagwörter: 
Cardiac resynchronization therapy (CRT)
Cost effectiveness
Optimization of CRT therapy
Persistent Identifier der Erstveröffentlichung: 
Creative-Commons-Lizenz: 
cc-by Logo
Dokumentart: 
Article

Datei(en):
Datei
Größe
1.03 MB





Publikationen in EconStor sind urheberrechtlich geschützt.